Valentis Announces Ruling on PEGylated Liposome Patent Infringement Litigation.

Publication: PR Newswire

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2002 PR Newswire Association LLC

Valentis, Inc. announced that its wholly-owned subsidiary, PolyMASC Pharmaceuticals Plc, has received a ruling in its patent infringement litigation against ALZA Corporation, a unit of Johnson & Johnson. The ruling received today followed a Markman hearing, in which the court decided the meaning of certain terms used in the patent claims at issue in the litigation. In the ruling, the district court adopted the claim interpretation proposed by ALZA. The Company intends to seek immediate disposition of the case at the district court level in order to bring the claim construction issues up for...

Read the full article for free courtesy of your local library.